Aidraelle Diario

Aidraelle Diario is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is used for birth control and may help manage acne and premenstrual symptoms. This medication is manufactured by Laboratorios Cinfa S.A. in the EU.

Aidraelle Diario is primarily used for contraception, helping to prevent pregnancy by regulating hormonal levels. It may also be prescribed to manage acne and alleviate symptoms of premenstrual dysphoric disorder (PMDD). This oral contraceptive works by inhibiting ovulation and altering the cervical mucus to prevent sperm from reaching the egg.

Common effects of Aidraelle Diario may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience breast tenderness, headaches, or nausea. These effects vary and typically subside as the body adjusts to the medication.

Aidraelle Diario should be used under medical supervision. It is important to inform your healthcare provider about any pre-existing conditions, especially those related to blood clots, liver disease, or high blood pressure. Regular follow-ups are recommended to monitor for any adverse effects.

Aidraelle Diario may interact with certain medications, including those that induce or inhibit liver enzymes, such as some antibiotics and anticonvulsants. It is advisable to consult a healthcare provider before combining Aidraelle Diario with other medications. Alcohol consumption should be moderated as it may affect the efficacy of the contraceptive.